Raphael Pharmaceutical Inc. (RAPH): Operating Income

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2023-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

-$1.25M
Year ended 2025-12-31
-$927.0K
Trailing 12 months to 2026-06-30
2020-12-31: -$706.0K2021-12-31: -$1.63M2022-12-31: -$3.32M2023-12-31: -$1.33M2024-12-31: -$1.51M2025-12-31: -$1.25M-$1.25M
2020-12-31 Operating Income (USD) 2025-12-31
Period endedOperating IncomeChange YoYSource filing
2025-12-31-$1.25Mn/m2026-03-31, From 2025-01-01
2024-12-31-$1.51Mn/m2026-03-31, From 2024-01-01
2023-12-31-$1.33Mn/c2025-03-31, From 2023-01-01
2022-12-31-$3.32Mn/m2024-03-28, From 2022-01-01
2021-12-31-$1.63Mn/m2023-05-25, From 2021-01-01
2020-12-31-$706.0Kn/a2022-03-30, From 2020-01-01

Operating Income at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating IncomeChange YoY
Raphael Pharmaceutical Inc. (RAPH)2025-12-31-$1.25Mn/m
China Foods Holdings Ltd. (CFOO)2025-12-31-$398.9Kn/m
Nutra Pharma Corp (NPHC)2025-12-31-$1.46Mn/m
Adia Nutrition, Inc. (ADIA)2025-12-31-$366.5Kn/m
Aibotics, Inc. (AIBT)2025-12-31-$1.84Mn/m
TFA Therapeutics, Inc. (RAJAF)2025-12-31-$141.1Kn/m
Regencell Bioscience Holdings Ltd (RGC)2025-06-30-$3.77Mn/m
Functional Brands Inc. (MEHA)2025-12-31-$1.40Mn/m
Synergy CHC Corp. (SNYRQ)2025-12-31-$8.46Mn/m

Compare RAPH, CFOO, NPHC, ADIA side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗